Clinical Roundup Talzenna + Xtandi improve OS in metastatic castration-resistant prostate cancer, phase III study finds February 14, 2025Vol.51 No.06
Clinical Roundup Chemo + immunotherapy may improve bladder preservation, interim data from phase II study show February 14, 2025Vol.51 No.06
Clinical Roundup Pain linked to increased tobacco and cannabis use among cancer survivors, study finds February 14, 2025Vol.51 No.06
Clinical Roundup Researchers identify gut bacteria as key to ovarian cancer immunotherapy resistance February 14, 2025Vol.51 No.06
Clinical Roundup Cortechs.ai, EDAP TMS announce OnQ prostate-assisted robotic HIFU procedure February 14, 2025Vol.51 No.06
Clinical Roundup Pre-surgery immunotherapy boosts breast cancer treatment success, phase III trial finds February 07, 2025Vol.51 No.05
Clinical Roundup Cancer vaccine shows promise for patients with stage 3 and 4 kidney cancer February 07, 2025Vol.51 No.05
Clinical Roundup UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects February 07, 2025Vol.51 No.05
Clinical Roundup Thyroid cancer continues to be overdiagnosed, Cedars-Sinai study finds February 07, 2025Vol.51 No.05
Clinical Roundup Inherited WNT9B mutation linked to increased prostate cancer risk, study finds February 07, 2025Vol.51 No.05